The SImpact Sacroiliac Joint Fixation System consists of two unique diameter cannulated implants offered in various lengths, in full and partially threaded configurations to accommodate variations in patient anatomy.
SImpact is intended for sacroiliac joint fusion for conditions including degenerative sacroiliitis and sacroiliac joint disruptions.
It offers controlled in-situ compression and distraction through a single insertion instrument.
SImpact incorporates Life Spine's new proprietary Osseo-Loc surface treatment, which provides an optimal environment to help promote bone fusion.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia